Refine by
Enzyme Replacement Therapy Equipment & Supplies In Canada
8 equipment items found
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO’s investigational gene therapy for Gaucher disease is being studied in a Phase 1/2 clinical trial to evaluate the safety and efficacy in individuals with Gaucher disease type 1. The trial is now enrolling in Canada, Australia and the U.S. The trial is intended to recruit 8 to 16 individuals between the ages of 16 and 35 with Gaucher disease type 1, including both ...
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) — a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase (GALNS). VIMIZIM works at a cellular level to help with deficient ...
Manufactured by:Newgen Biotech(Ningbo) Co.,Ltd based inXiangshan County, CHINA
Melibiose, also known as melibiase, can be used to improve and eliminate anti-nutritional ingredients in feed and soy foods. It can realize B→O blood group transformation, prepare universal blood type, and play an important role in enzyme replacement therapy of Fabry disease in the medical field. It can also act on complex polysaccharides ...
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
Brineura (cerliponase alfa) is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is the first enzyme replacement therapy to be directly administered into the fluid of ...
Manufactured by:Evox Therapeutics Limited based inOxford, UNITED KINGDOM
The Evox portfolio includes granted and pending applications in the world's major pharmaceutical markets, including USA, Europe, Japan, China as well as various other jurisdictions. In addition to the patent portfolio Evox also safeguards its intellectual property by the maintenance of several trademarks, copyrights, and trade secrets which together form broad and deep protection for the ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
FW-EPI (adrulipase) is a recombinant lipase enzyme administered as an oral, non-systemic biologic capsule for the treatment of exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP). Adrulipase is derived from the Yarrowia lipolytica yeast lipase and is designed to break up fat molecules in the digestive tract of EPI patients so that they can be ...
by:Genova Diagnostics based inAsheville,, NORTH CAROLINA (USA)
A Non-Invasive Stool Biomarker of Pancreatic Exocrine Function. Pancreatic elastase is a protein-digesting enzyme exclusively produced by the human pancreas, and serves as a non-invasive stool biomarker of pancreatic exocrine function. Pancreatic elastase measured in stool has a strong correlation with the invasive gold-standard test for pancreatic insufficiency and, therefore, is a ...
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected patients with the Scheie form have not been established. ALDURAZYME has been shown to improve pulmonary function and walking capacity. ALDURAZYME has ...